May 2, 2024
In this episode, host Shikha Jain, MD, speaks
with Sean Bohen, MD, about how cancer therapies
are changing how oncology can be discussed, shifting from clinical
to industry work and more.
• Welcome to another exciting episode of Oncology
Overdrive :58
• About Bohen 1:04
• The interview 1:30
• Tell us about your journey. How did you become an
oncologist, and how did you make the transition into working in the
pharmaceutical industry? 1:51
• How did you end up at Olema Oncology after working
with other pharmaceutical companies? What was your decision-making
process to focus on the industry part of your career?
3:44
• Tell us more about what Olema Oncology does and what
your role is there. 6:30
• What do you see coming down the pipeline for breast
cancer research and innovation? … What do you think Olema will
contribute to that space? 8:58
• Bohen and Jain on the ways in which new treatments
have resulted in shifting conversations around cancer care and
patient quality of life. 12:45
• If someone in fellowship is interested in working in
industry, pharmaceuticals or scientific development, what are the
most effective ways to get into this space?
18:21
• Jain and Bohen on changing the mindset and
misconceptions around moving between clinical, academic and
industry work within the field and after fellowship.
20:52
• What do you see happening in the oncology landscape
twenty years from now? 25:46
• If someone could only listen to the last two minutes
of this episode, what would you want them to take away?
29:19
• How to contact Bohen
30:54
• Thanks for listening
31:52
Sean Bohen, MD, is the President and CEO of Olema
Oncology.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at oncologyoverdrive@healio.com.
Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/.
Follow Dr. Jain on X:
@ShikhaJainMD. Bohen can be reached at olema.com.
Disclosures: Jain and Bohen report no relevant
financial disclosures.